Edesa Biotech, Inc. (EDSA) stock
EDSANasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 6/30
$1.89−0.05 (-2.58%)
Close on Nov 16, 2026Market cap $18.22MP/E –Yield –
Edesa Biotech operating margin
Operating margin is operating income as a percentage of revenue.
Edesa Biotech's operating margin for the twelve months ending Jun 30, 2021 was -4041457.2%. For fiscal 2020 it was -1946.7%, against -2397.1% the year before. The highest annual figure on record is -386.0% in fiscal 2016.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2020 | Sep 30, 2020 | -1946.7% | +450.4 |
| FY2018 | Sep 30, 2018 | -2397.1% | −108.5 |
| FY2017 | Sep 30, 2017 | -2288.6% | −1902.6 |
| FY2016 | Sep 30, 2016 | -386.0% | +1150.7 |
| FY2014 | Aug 31, 2014 | -1536.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | -402094.8% | −138024.0 |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | -1607.9% | +578.2 |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | -1372.0% | +726.1 |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | -1025.7% | +5758.5 |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | -264070.8% | −216539.7 |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | -2186.1% | +4114.4 |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | -2098.1% | −277.1 |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | -6784.2% | −5787.1 |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | -47531.1% | −47054.3 |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | -6300.5% | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | -1821.0% | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | -997.1% | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | -476.8% | – |
See a number that looks wrong?